GENEVA, July 18 -- VANDA PHARMACEUTICALS INC. filed a patent application (US2026/010827) for “METHOD OF TREATING NAUSEA AND VOMITING AFTER GLP-1R AGONIST ADMINISTRATION”. With publication no. WO/2026/152024, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/444

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....